“…As an emerging translation field, radiomics investigates the association between quantitative high-dimensional data extracted from imaging examinations and clinical data to construct a prediction model, which eventually improves evidence-based personalized medical decision-making [12,13]. In recent years, radiomics has shown great promise in predicting tumor diagnosis, molecular subtype, therapeutic effect, and survival in patients with various tumor types, including breast cancer [14,15], lung cancer [16,17], and OC [18][19][20]. A systematic review demonstrated that radiomics models have shown promising results as predictors of OS and progression-free survival (PFS) in patients with OC, but larger studies are needed to demonstrate clinical applicability [20].…”